227 related articles for article (PubMed ID: 30655272)
21. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes.
Bredius RG; Fijen CA; De Haas M; Kuijper EJ; Weening RS; Van de Winkel JG; Out TA
Immunology; 1994 Dec; 83(4):624-30. PubMed ID: 7875742
[TBL] [Abstract][Full Text] [Related]
22. Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcgammaRIIIA/CD16.
de Romeuf C; Dutertre CA; Le Garff-Tavernier M; Fournier N; Gaucher C; Glacet A; Jorieux S; Bihoreau N; Behrens CK; Béliard R; Vieillard V; Cazin B; Bourel D; Prost JF; Teillaud JL; Merle-Béral H
Br J Haematol; 2008 Mar; 140(6):635-43. PubMed ID: 18302712
[TBL] [Abstract][Full Text] [Related]
23. Influence of FcγRIIIb polymorphism on its ability to cooperate with FcγRIIa and CR3 in mediating the oxidative burst of human neutrophils.
Urbaczek AC; Toller-Kawahisa JE; Fonseca LM; Costa PI; Faria CM; Azzolini AE; Lucisano-Valim YM; Marzocchi-Machado CM
Hum Immunol; 2014 Aug; 75(8):785-90. PubMed ID: 24945596
[TBL] [Abstract][Full Text] [Related]
24. Soluble Fcgamma receptor IIIb alters the function of polymorphonuclear neutrophils but extends their survival.
Durand V; Pers JO; Renaudineau Y; Youinou P; Jamin C
Eur J Immunol; 2001 Jul; 31(7):1952-61. PubMed ID: 11449347
[TBL] [Abstract][Full Text] [Related]
25. HNA-1d: a new human neutrophil antigen located on Fcγ receptor IIIb associated with neonatal immune neutropenia.
Reil A; Sachs UJ; Siahanidou T; Flesch BK; Bux J
Transfusion; 2013 Oct; 53(10):2145-51. PubMed ID: 23347194
[TBL] [Abstract][Full Text] [Related]
26. Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors.
Isoda Y; Yagi H; Satoh T; Shibata-Koyama M; Masuda K; Satoh M; Kato K; Iida S
PLoS One; 2015; 10(10):e0140120. PubMed ID: 26444434
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of human FcgammaRIIA (CD32) and FcgammaRIIIB (CD16) polymorphisms in Caucasians and African-Americans using salivary DNA.
van Schie RC; Wilson ME
Clin Diagn Lab Immunol; 2000 Jul; 7(4):676-81. PubMed ID: 10882671
[TBL] [Abstract][Full Text] [Related]
28. Relevance of IgG receptor IIIb (CD16) polymorphism to handling of Porphyromonas gingivalis: implications for the pathogenesis of adult periodontitis.
Kobayashi T; van der Pol WL; van de Winkel JG; Hara K; Sugita N; Westerdaal NA; Yoshie H; Horigome T
J Periodontal Res; 2000 Apr; 35(2):65-73. PubMed ID: 10863960
[TBL] [Abstract][Full Text] [Related]
29. Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
Brandsma AM; Bondza S; Evers M; Koutstaal R; Nederend M; Jansen JHM; Rösner T; Valerius T; Leusen JHW; Ten Broeke T
Front Immunol; 2019; 10():704. PubMed ID: 31031746
[TBL] [Abstract][Full Text] [Related]
30. Association between Fcγ receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya.
Munde EO; Okeyo WA; Raballah E; Anyona SB; Were T; Ong'echa JM; Perkins DJ; Ouma C
BMC Infect Dis; 2017 Apr; 17(1):289. PubMed ID: 28427365
[TBL] [Abstract][Full Text] [Related]
31. An Engineered Human Fc variant With Exquisite Selectivity for FcγRIIIa
Kang TH; Lee CH; Delidakis G; Jung J; Richard-Le Goff O; Lee J; Kim JE; Charab W; Bruhns P; Georgiou G
Front Immunol; 2019; 10():562. PubMed ID: 30984171
[TBL] [Abstract][Full Text] [Related]
32. Variations in genes encoding neutrophil antigens NA1 and NA2.
Matsuo K; Procter J; Stroncek D
Transfusion; 2000 Jun; 40(6):645-53. PubMed ID: 10864983
[TBL] [Abstract][Full Text] [Related]
33. Membrane Transfer from Mononuclear Cells to Polymorphonuclear Neutrophils Transduces Cell Survival and Activation Signals in the Recipient Cells via Anti-Extrinsic Apoptotic and MAP Kinase Signaling Pathways.
Li KJ; Wu CH; Shen CY; Kuo YM; Yu CL; Hsieh SC
PLoS One; 2016; 11(6):e0156262. PubMed ID: 27258015
[TBL] [Abstract][Full Text] [Related]
34. ATTACHMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS BY AUTOLOGOUS POLYMORPHONUCLEAR NEUTROPHILS MEDIATED BY BISPECIFIC ANTI-CD19/CD64 ANTIBODY.
Tsertsvadze T; Mitskevich N; Datikashvili-David I; Ghirdaladze D; Porakishvili N
Georgian Med News; 2020 Nov; (308):118-123. PubMed ID: 33395652
[TBL] [Abstract][Full Text] [Related]
35. Hypoxemia up-regulates interleukin-8 stimulated phagocytosis of polymorphonuclear leukocytes by differential regulation of CD32w and CD35 messenger RNA expression.
Knowles R; Keeping H; Nguyen K; Garner C; D'Amico R; Simms HH
Surgery; 1995 Aug; 118(2):177-83; discussion 183-4. PubMed ID: 7638731
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the neutrophilic antibody-dependent respiratory burst (ADRB) response to Plasmodium falciparum.
Kapelski S; Klockenbring T; Fischer R; Barth S; Fendel R
J Leukoc Biol; 2014 Dec; 96(6):1131-42. PubMed ID: 25118179
[TBL] [Abstract][Full Text] [Related]
37. Fcγ receptors on aging neutrophils.
Gasparoto TH; Dalboni TM; Amôr NG; Abe AE; Perri G; Lara VS; Vieira NA; Gasparoto CT; Campanelli AP
J Appl Oral Sci; 2021; 29():e20200770. PubMed ID: 33825754
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment.
Cartron G; Ohresser M; Salles G; Solal-Céligny P; Colombat P; Watier H
Ann Oncol; 2008 Aug; 19(8):1485-1487. PubMed ID: 18408222
[TBL] [Abstract][Full Text] [Related]
39. C-reactive protein triggers calcium signalling in human neutrophilic granulocytes via FcγRIIa in an allele-specific way.
Aas V; Sand KL; Asheim HC; Benestad HB; Iversen JG
Scand J Immunol; 2013 Jun; 77(6):442-51. PubMed ID: 23551080
[TBL] [Abstract][Full Text] [Related]
40. Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa.
Iida S; Misaka H; Inoue M; Shibata M; Nakano R; Yamane-Ohnuki N; Wakitani M; Yano K; Shitara K; Satoh M
Clin Cancer Res; 2006 May; 12(9):2879-87. PubMed ID: 16675584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
